Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

DANIEL SCHWARTZ

Allopathic & Osteopathic Physicians Psychiatry & Neurology Neurology

NPI
1417244211
CMS profile
1001657
Location
CARMEL, NY

General Payments · PY2018–2023

$47,610.02

  • Reported across 45 records
  • CMS publication 2026-01-23

Latest program year · PY2023

$13,794.47

12 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2023 · sorted by reported total

By paying entity

PY2023 · sorted by reported total

Paying entityAmountRecords
ABBVIE INC. $12,000.00 3
LivaNova USA, Inc. $1,584.96 4
Genentech USA, Inc. $147.82 1
ACADIA Pharmaceuticals Inc $61.69 4

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $4,502.60 10
PY2019 $7,645.00 5
PY2020 $8,380.00 4
PY2021 $8,787.42 5
PY2022 $4,500.53 9
PY2023 $13,794.47 12

Payment records · PY2023 (12)

Sorted by paying entity, then date · as published by CMS

Program year 2023 20182019202020212022 Record-level detail is published for PY2023; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
AbbVie Inc. $4,000.00 06/02/2023 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 998881665 CMS
AbbVie Inc. $4,000.00 06/07/2023 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 998881669 CMS
AbbVie Inc. $4,000.00 07/11/2023 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 998881673 CMS
ACADIA Pharmaceuticals Inc $12.81 03/02/2023 Food and Beverage Undisputed 01/23/2026 1053163671 CMS
ACADIA Pharmaceuticals Inc $17.72 04/18/2023 Food and Beverage Undisputed 01/23/2026 1053163673 CMS
ACADIA Pharmaceuticals Inc $14.81 06/07/2023 Food and Beverage Undisputed 01/23/2026 1053163677 CMS
ACADIA Pharmaceuticals Inc $16.35 07/19/2023 Food and Beverage Undisputed 01/23/2026 1053163681 CMS
Genentech USA, Inc. $147.82 11/01/2023 Food and Beverage Undisputed 01/23/2026 1040337941 CMS
LivaNova USA, Inc. $266.27 04/14/2023 Travel and Lodging Undisputed 01/23/2026 1042992915 CMS
LivaNova USA, Inc. $523.90 04/14/2023 Travel and Lodging Undisputed 01/23/2026 1042992927 CMS
LivaNova USA, Inc. $313.50 04/14/2023 Travel and Lodging Undisputed 01/23/2026 1042992937 CMS
LivaNova USA, Inc. $481.29 04/15/2023 Food and Beverage Undisputed 01/23/2026 1042992949 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023
Generated from
OP_DTL_GNRL_PGYR2023_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.